Aethlon Medical Inc income statement

In fiscal 2024, Aethlon Medical Inc reported revenue of $0, down 100.0% on the year before and net income of −$12.2m, or −$38.87 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Aethlon Medical Inc: income statement, annual
Fiscal year	2012Mar 2012	2013Mar 2013	2014Mar 2014	2015Mar 2015	2016Mar 2016	2017Mar 2017	2018Mar 2018	2019Mar 2019	2020Mar 2020	2021Mar 2021	2022Mar 2022	2023Mar 2023	2024Mar 2024
Revenue	1	1	2	1	1	0	0	0	1	1	0	1	0
Research and development	—	1	2	1	1	1	1	1	1	2	2	3	3
General and administrative	1	1	1	1	1	1	1	1	2	2	3	4	4
Operating income	−3	−4	−3	−4	−4	−6	−5	−6	−6	−8	−10	−12	−13
Interest expense	—	—	1	0	0	—	—	—	—	—	—	—	—
Income tax	—	0	0	0	0	0	0	0	0	0	0	0	0
Net income	−8	−5	−13	−7	−5	−7	−6	−6	−6	−8	−10	−12	−12
Diluted EPS	−$4.00	−$1800.00	−$4128.00	−$1.22	−$0.66	−$0.94	−$120.00	−$410.40	−$149.60	−$52.00	−$0.71	−$46.88	−$38.87
Diluted shares (average)	—	—	—	—	6m	6m	10m	15m	—	—	—	—	—
EBITDA	−3	−4	−3	−4	−4	−6	−5	−6	−6	−8	−10	−12	−12

US$ thousands unless shown otherwise. Fiscal quarters.

Aethlon Medical Inc: income statement, quarterly
Quarter	2022 Q1Jun 2021	2022 Q2Sept 2021	2022 Q3Dec 2021	2022 Q4Mar 2022	2023 Q1Jun 2022	2023 Q2Sept 2022	2023 Q3Dec 2022	2023 Q4Mar 2023
Revenue	132	132	17	13	0	0	0	574
Research and development	588	478	355	937	858	852	558	616
General and administrative	630	686	1,112	1,027	1,032	1,548	1,071	827
Operating income	−2,098	−2,009	−2,528	−3,786	−2,906	−3,665	−2,850	−2,478
Interest expense	0	—	—	—	—	—	—	—
Net income	−2,097	−2,008	−2,526	−3,785	−2,906	−3,807	−2,850	−2,467
Diluted EPS	−$0.16	−$0.13	−$0.16	−$0.25	−$0.19	−$1.84	−$1.24	−$8.16
EBITDA	−2,087	−1,940	−2,510	−3,760	−2,875	−3,613	−2,772	−2,398

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Aethlon Medical Inc's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aethlon Medical Inc.